CompletedNCT03142516
FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status
PHASE2 · 20 planned enrolment
- Countries listed
- 1
- Registry update
- June 21, 2021
